ArticleBreast cancer research and treatment2019

The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast.

Ulrik Narbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.